Jason Glanz to Measles-Mumps-Rubella Vaccine
This is a "connection" page, showing publications Jason Glanz has written about Measles-Mumps-Rubella Vaccine.
Connection Strength
0.926
-
Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006 Aug; 59(8):808-18.
Score: 0.257
-
The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes. Pediatrics. 2021 12 01; 148(6).
Score: 0.191
-
Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun; 133(6):e1492-9.
Score: 0.114
-
A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Stat Med. 2013 Aug 30; 32(19):3290-9.
Score: 0.103
-
Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012 May; 129(5):809-14.
Score: 0.098
-
Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2011 Mar 30; 30(7):742-52.
Score: 0.089
-
Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008 Mar; 121(3):e687-92.
Score: 0.074